Post-operative Urinary Retention (POUR) Following Thoracic Surgery

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions
Urinary Retention
Interventions
DRUG

Tamsulosin - 1 week

The investigators hypothesize that pre-operative administration of Tamusolin (Flomax, 0.4mg/day x 1 week), with ongoing use post-operatively until normal voiding resumes, will result in a significant decrease in the incidence of POUR after a thoracic surgical procedure.

DRUG

Tamsulosin - 3 days

The investigators hypothesize that pre-operative administration of Tamusolin (Flomax, 0.4mg/day x 3 days), with ongoing use post-operatively until normal voiding resumes, will result in a significant decrease in the incidence of POUR after a thoracic surgical procedure.

Trial Locations (1)

07601

RECRUITING

Daniel Mansour, Hackensack

All Listed Sponsors
lead

Hackensack Meridian Health

OTHER